The demands for traceability, anti-counterfeiting, and transparency are increasing – both from a regulatory and technological perspective. At the same time, the implementation of digital labeling systems is becoming increasingly complex: different technologies, diverse regulations, and demanding validation processes.
In the fields of pharmaceuticals, diagnostics, and medical technology, digital product labeling is no longer an option but a prerequisite for ensuring safety, quality, and efficiency.
Röchling Medical has carried out a comprehensive analysis of these technologies, their potential applications, and the relevant regulatory frameworks. In our Technology Paper, we provide practical insights into which solutions are already available, how they work, and what is crucial for successful implementation.
Digital product labeling is more than just technology – it is a decisive factor in product safety and transparency throughout the value chain.
In the healthcare market, a wide range of approaches is emerging: from established methods such as RFID and laser marking to innovative concepts like Magic Ink or SmartMarker®. But which technology is suitable for which application? And how can regulatory requirements, material properties, and production processes be brought together effectively?
Our paper provides orientation. It outlines the most important developments around proven and emerging technologies, explains how they work, and shows how manufacturers can meaningfully integrate them into their development and production processes.
The Technology Paper offers practical approaches for evaluating and integrating digital product labeling systems.
For more information about digital product labeling or our development services, please contact our team.
We look forward to hearing from you.

Erika Unjaev
Head of Innovation